Radiation Adaptive Response Induced by I-131 Therapy in Patients with Differentiated Thyroid Cancer.
- Author:
Ming Hao LI
;
Hee Seung BOM
- Publication Type:Original Article
- Keywords:
Radiation adaptive response;
I-131 therapy;
Lymphocytes;
Thyroid cancer
- MeSH:
Chromosome Aberrations;
Cycloheximide;
Female;
Gamma Rays;
Humans;
Lymphocytes;
Male;
Thyroid Gland*;
Thyroid Neoplasms*
- From:Korean Journal of Nuclear Medicine
2001;35(2):83-88
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
PURPOSE: The purpose of this study was to ascertain whether radiation adaptive response could be induced by high dose I-131 therapy in patients with differentiated thyroid cancer. MATERIALS AND METHODS: Lymphocytes from 21 patients (7 males, 14 females, mean age 55+/-12 years) were collected before and after administration of 5,550 MBq (150 mCi) I-131. They were exposed to a challenge dose of 1 Gy gamma rays using a Cs-137 cell irradiator. The number of ring-form (R) and dicentric (D) chromosomes was counted under the light microscope, and used to calculate the frequency of chromosomal aberration. Ydr, which was defined as the sum of R and D divided by the total number of counted lymphocytes. RESULTS: Ydr in patients before I-131 therapy (0.09+/-0.01) was not different from that of controls (0.08+/-0.01). Ydr was significantly increased to 0.13+/-0.02 (p<0.0001) after I-131 therapy. Increase of Ydr after the challenge irradiation of 1 Gy was significantly lower in patients after I-131 therapy than before I-131 therapy (0.17+/-0.03 vs 0.21+/-0.02, p<0.0001). Cycloheximide (CHM), an inhibitor of protein synthesis, abolished this effect. Ydr after CHM (0.20+/-0.01) was significantly higher than Ydr after I-131 therapy (0.17+/-0.03, p<0.0001), but was not different from Ydr before I-131 therapy (0.21+/-0.02). CONCLUSION: High dose I-131 therapy induces an adaptive response in peripheral lymphocytes of patients with well-differentiated thyroid cancer, which is associated with protein synthesis.
